Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

HR-756

Known as: HR 756, HR756 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2003
2003
A total of 434 clinical aerobic gram-negative bacillary isolates were tested against LY127935, a new 1-oxa cephalosporin, and… Expand
  • table 1
Is this relevant?
1981
1981
Cefodizime (HR221) is a new alpha-methoxyimino cephalosporin developed by Hoechst-Roussel with a reported serum half-life of over… Expand
Is this relevant?
1981
1981
To measure the susceptibility of penicillin-resistant pneumococci to newer beta-lactam agents, we evaluated 54 selected strains… Expand
Is this relevant?
1981
1981
Twenty adult surgical patients aged between 15 and 83 years (mean:45), 10 of whom had wound infections (one complicated with… Expand
Is this relevant?
1980
1980
The desacetyl metabolite (DES) of cefotaxime (HR756) is formed in vivo to a significant extent. The in vitro activities of DES… Expand
Is this relevant?
1980
1980
Moxalactam (LY127935) exhibited greater in vitro activity than cefamandole and tobramycin against clinical isolates of… Expand
Is this relevant?
1980
1980
The in vitro activities of two new beta-lactam antibiotics, moxalactam disodium (LY 127935) and cefotaxime (HR-756), were… Expand
  • table 1
  • table 3
  • table 4
  • table 5
Is this relevant?
1979
1979
The in vitro activities of LY127935 (LY) were compared with those of other beta-lactam antibiotics. LY was highly active (minimal… Expand
Is this relevant?
1979
1979
Azlocillin, carbenicillin, cefsulodin, mezlocillin, nocardicin A, piperacillin, pirbenicillin, sulbenicillin, and ticarcillin… Expand
Is this relevant?
1978
1978
The in vitro activity of HR756, a new semisynthetic cephalosporin, was compared with the activities of cephalothin, cefoxitin… Expand
  • table 1
  • table 2
  • table 3
Is this relevant?